Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer.

MLA

Harris, A. L., et al. “Comparison of Short-Term and Continuous Chemotherapy (Mitozantrone) for Advanced Breast Cancer.” Lancet (London, England), vol. 335, no. 8683, Jan. 1990, pp. 186–90. EBSCOhost, https://doi.org/10.1016/0140-6736(90)90277-c.

APA

Harris, A. L., Cantwell, B. M., Carmichael, J., Wilson, R., Farndon, J., Dawes, P., Ghani, S., & Evans, R. G. (1990). Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer. Lancet (London, England), 335(8683), 186–190. https://doi.org/10.1016/0140-6736(90)90277-c

Chicago

Harris, A L, B M Cantwell, J Carmichael, R Wilson, J Farndon, P Dawes, S Ghani, and R G Evans. 1990. “Comparison of Short-Term and Continuous Chemotherapy (Mitozantrone) for Advanced Breast Cancer.” Lancet (London, England) 335 (8683): 186–90. doi:10.1016/0140-6736(90)90277-c.